# US 2010/0168137 A1 · Combination for use in the treatment of inflammatory disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168137 A1
- Document ID: US20100168137A1
- Status: Published application
- Kind: A1
- Application number: 12/448,323
- Filed: 2007-12-18
- Published: 2010-07-01
- Earliest claimed: 2006-12-20
- Inventors: Johan Raud
- Web page: https://patentgrep.com/patent/US20100168137A1

## CPC

- A61K 31/403: condensed with carbocyclic rings, e.g. carbazole
- A61K 31/519: ortho- or peri-condensed with heterocyclic rings
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 11/06: Antiasthmatics
- A61P 17/06: Antipsoriatics
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 25/06: Antimigraine agents
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 37/00: Drugs for immunological or allergic disorders
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

There is provided combination products comprising (a) pemirolast, or a pharmaceutically-acceptable salt or solvate thereof; and (b) ramatroban, or a pharmaceutically-acceptable salt or solvate thereof. Such combination products find particular utility in the treatment of atherosclerosis and related conditions.

## Claims

### Claim 1

A combination product comprising:
(a) pemirolast, or a pharmaceutically-acceptable salt or solvate thereof; and
(b) ramatroban, or a pharmaceutically-acceptable salt or solvate thereof.

### Claim 2 (depends on 1)

A combination product as claimed in claim 1, which comprises a pharmaceutical formulation including pemirolast, or a pharmaceutically-acceptable salt or solvate thereof; ramatroban, or a pharmaceutically-acceptable salt or solvate thereof; and a pharmaceutically-acceptable adjuvant, diluent or carrier.

### Claim 3 (depends on 1)

A combination product as claimed in claim 1, which comprises a kit of parts comprising components:
(A) a pharmaceutical formulation including pemirolast, or a pharmaceutically-acceptable salt or solvate thereof, in admixture with a pharmaceutically-acceptable adjuvant, diluent or carrier; and
(B) a pharmaceutical formulation including ramatroban, or a pharmaceutically-acceptable salt or solvate thereof, in admixture with a pharmaceutically-acceptable adjuvant, diluent or carrier,
which components (A) and (B) are each provided in a form that is suitable for administration in conjunction with the other.

### Claim 4

(canceled)

### Claim 5 (depends on 3)

A kit of parts according to claim 3 further comprising:
(I) of components (A) and (B) as defined in claim 3; together with
(II) instructions to use that component in conjunction with the other of the two components.

### Claim 6 (depends on 3)

A kit of parts as claimed in claim 3, wherein components (A) and (B) are suitable for sequential, separate and/or simultaneous use in the treatment of an inflammatory disorder.

### Claim 7

(canceled)

### Claim 8 (depends on 1)

A method of treatment of an inflammatory disorder, which method comprises the administration of a combination product as defined in claim 1, to a patient in need of such treatment.

### Claim 9 (depends on 6)

A kit of parts as claimed in claim 6, wherein the disorder is selected from migraine, asthma, chronic obstructive pulmonary disease, Crohn's disease, multiple sclerosis, psoriasis, rheumatoid arthritis, systemic lupus erythematosus or ulcerative colitis.

### Claim 10 (depends on 6, 8)

A kit of parts as claimed in claim 6, claim 8, wherein the disorder is atherosclerosis or an associated cardiovascular disorder.

### Claim 11 (depends on 10)

A kit of parts, as claimed in claim 10, wherein the disorder is atherosclerosis.

### Claim 12 (depends on 10)

A kit of parts, as claimed in claim 10, wherein the cardiovascular disorder associated with atherosclerosis is selected from an aortic aneurysm, arteriosclerosis, peripheral arterial occlusive disease, a coronary artery disease, a coronary disease, plaque rupture, atheroma rupture and/or instability, a vascular disease, an arterial disease, an ischemic disease, ischemia and stroke.

### Claim 13 (depends on 12)

A kit of parts, as claimed in claim 12, wherein the coronary artery disease is selected from angina pectoris, myocardial infarction and heart attack.

### Claim 14 (depends on 12)

A kit of parts, as claimed in claim 12, wherein the coronary disease is selected from a cardiac disease and a heart disease.

### Claim 15 (depends on 12)

A kit of parts, as claimed in claim 12, wherein the stroke is selected from cerebro-vascular accident and transient ischaemic attack.

### Claim 16 (depends on 6)

A kit of parts, as claimed in claim 6, wherein the patient has an acute coronary syndrome.
